Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials

Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents

(2011) Lorenz Räber et al.   CIRCULATION

Everolimus-Eluting Versus Sirolimus-Eluting Stents

(2011) Antoinette de Waha et al.   Circulation-Cardiovascular Interventions

Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

(2011) Robert A. Byrne et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of Inflammatory Response After Implantation of Sirolimus- and Paclitaxel-Eluting Stents in Porcine Coronary Arteries

(2009) Gregory J. Wilson et al.   CIRCULATION

Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis

(2009) Stéphane Cook et al.   CIRCULATION

Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberté Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries

(2009) Bernard Chevalier et al.   Circulation-Cardiovascular Interventions

Drug-Eluting Stents in Percutaneous Coronary Intervention

(2009) Robert A. Byrne et al.   DRUG SAFETY

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

(2009) R. A. Byrne et al.   EUROPEAN HEART JOURNAL

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

(2009) P. Barlis et al.   EUROPEAN HEART JOURNAL

Temporal Course of Neointimal Formation After Drug-Eluting Stent Placement

(2009) Aloke V. Finn et al.   JACC-Cardiovascular Interventions

Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer

(2009) Robert A. Byrne et al.   JACC-Cardiovascular Interventions

Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients

(2008) Gaku Nakazawa et al.   CIRCULATION

Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis

(2008) J. Mehilli et al.   EUROPEAN HEART JOURNAL

Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice

(2008) Peter Wenaweser et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

(2008) Stephan Windecker et al.   LANCET

A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications

(2008) Oscar C. Marroquin et al.   NEW ENGLAND JOURNAL OF MEDICINE